Tempus AI, Inc. (TEM) vs 10x Genomics (TXG)
Tempus AI, Inc. and 10x Genomics are both Health Information Services companies. Tempus AI, Inc. is the larger, with a market value of $14.9B against $11.1B — 1.3× the size. Tempus AI, Inc. grew revenue faster over the last twelve months: 50.4% against −4.28%. 10x Genomics has the higher net margin (−12.2% vs −17.8%) and the lower return on invested capital (−20.2% vs −17.9%). Across the 17 metrics below, 10x Genomics leads on 11 and Tempus AI, Inc. on 6.
Valuation
Profitability
| Metric | TEM | TXG | Health Information Services median |
|---|---|---|---|
| Gross margin | 63.98% | 70.03% | 63.38% |
| Operating margin | (19.76%) | (14.33%) | (8.35%) |
| Net margin | (17.77%) | (12.18%) | (14.70%) |
| Free cash flow margin | (19.06%) | 19.68% | 0.58% |
| Return on equity | (67.44%) | (9.40%) | (6.82%) |
| Return on assets | (12.75%) | (7.47%) | (6.02%) |
| Return on invested capital | (17.87%) | (20.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack